New signaling pathway linked to inflammatory disease discovered
December 15th, 2010 - 4:33 pm ICT by ANIWashington, Dec 15 (ANI): Scientists have described for the first time a key inhibitory role for the IL-1 signaling pathway in the human innate immune system, providing novel insights into human inflammatory bowel disease (IBD) and potential new treatments.
The research was led by Jose M. Gonzalez-Navajas and Eyal Raz, a professor of medicine at UC San Diego,
The researchers found that signaling by the interleukin 1 receptor (IL-1R) controls expression of a protein called DUBA (deubquitinase A), which in turn affects production of anti-inflammatory cytokines reacting to certain bacterial stimuli.
Cytokines are molecules that help trigger an immune system response to infections and cancer. Some induce inflammation whereas some suppress it.
The IL-1R is essential to producing key anti-inflammatory cytokines like IL-10 and type 1 interferon, but genetic alterations, infection and some drugs can disrupt the signaling process, resulting in reduced or increased cytokine production that upsets delicate balances and leads to disease.
The authors said the research also revealed the deleterious effects of some anti-inflammatory drugs. IL-1 is a pro-inflammatory cytokine implicated in certain conditions like rheumatoid arthritis and gout, the latter a painful inflammation of the toes and feet.
The authors propose that several drugs currently used to treat these conditions by blocking IL-1 activity could be harmful to patients suffering from IBD, which generally involves an overwhelming immune response against normal, non-pathogenic gut bacteria.
“Our findings indicate that the use of such drugs can be harmful and therefore should be avoided in such patients,” said Raz.
The study has been published in The Journal of Experimental Medicine. (ANI)
- Protein that may fight against inflammatory disease identified - Oct 21, 2010
- New drug target for inflammatory bowel disease found - Apr 01, 2011
- How reovirus kills cancer cells - Feb 21, 2011
- Gut bug may hold key to inflammatory bowel disease treatment - Jan 20, 2010
- Mice study finds link between depression and inflammatory response - Dec 21, 2010
- 'Fountain of youth' pill may restore aging immune system - Dec 14, 2010
- Probiotic bacteria 'could help in Crohn's disease therapy' - Apr 01, 2011
- Tart cherries may reduce inflammation, risk factors for heart disease - Apr 13, 2011
- Cell killer enzyme could help cancer treatment - Mar 06, 2011
- 'Master switch' for key immune cells in inflammatory diseases found - Jan 17, 2011
- Prozac, Celexa show promise for rheumatoid arthritis treatment - Feb 25, 2010
- Compound in carrots, peppers boosts brain health - Oct 14, 2010
- Protein that modulates metabolic dysfunction in obesity identified - Jun 18, 2010
- Green peppers, chamomile tea may protect against inflammation - Jul 09, 2010
- DNA damage can help protect the body from infection - Apr 01, 2011
Tags: anti inflammatory drugs, deleterious effects, delicate balances, eyal, genetic alterations, gut bacteria, immune system response, inflammatory bowel disease, inflammatory cytokines, inflammatory disease, inhibitory role, innate immune system, interferon, interleukin 1, journal of experimental medicine, navajas, novel insights, painful inflammation, rheumatoid arthritis, uc san diego